Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept rescue therapy after secondary failure to monoclonal antibody TNF inhibitors in rheumatoid arthritis
2009-017379-90Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Mar 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA), sponsored by Azienda Ospedaliera Universitaria Senese. Started Mar 2010; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-017379-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017379-90.